CO6341477A2 - Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestos - Google Patents
Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestosInfo
- Publication number
- CO6341477A2 CO6341477A2 CO10071529A CO10071529A CO6341477A2 CO 6341477 A2 CO6341477 A2 CO 6341477A2 CO 10071529 A CO10071529 A CO 10071529A CO 10071529 A CO10071529 A CO 10071529A CO 6341477 A2 CO6341477 A2 CO 6341477A2
- Authority
- CO
- Colombia
- Prior art keywords
- compounds
- pirrolopirimidincarboxamida
- processes
- production
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Los compuestos de la fórmula (I)en donde R1, R21, R22, R23, R24, Y y R3 tienen los significados dados en la descripción, las sales de los mismos, los N-óxidos de los compuestos, y las sales de los mismos y los estereoisómeros de los compuestos, las sales, los N-óxidos de los compuestos y los N-óxidos de las sales de los mismos, son efectivos inhibidores de la fosfodiesterasa tipo 5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08102052 | 2008-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6341477A2 true CO6341477A2 (es) | 2011-11-21 |
Family
ID=39855184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO10071529A CO6341477A2 (es) | 2008-02-27 | 2010-06-15 | Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestos |
Country Status (21)
Country | Link |
---|---|
US (1) | US8445501B2 (es) |
EP (1) | EP2247594A1 (es) |
JP (1) | JP5615187B2 (es) |
KR (1) | KR20100136469A (es) |
CN (1) | CN101959890B (es) |
AR (1) | AR070454A1 (es) |
AU (1) | AU2009218507B2 (es) |
BR (1) | BRPI0907863A2 (es) |
CA (1) | CA2711733A1 (es) |
CO (1) | CO6341477A2 (es) |
EA (1) | EA018331B1 (es) |
EC (1) | ECSP10010425A (es) |
HK (1) | HK1153200A1 (es) |
IL (1) | IL207639A (es) |
MX (1) | MX2010009276A (es) |
MY (1) | MY152061A (es) |
NZ (1) | NZ586486A (es) |
SG (1) | SG188823A1 (es) |
TW (1) | TW200944527A (es) |
UA (1) | UA101018C2 (es) |
WO (1) | WO2009106531A1 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2297114T (pt) | 2008-06-19 | 2018-07-26 | Takeda Pharmaceuticals Co | Composto heterocíclico e a sua utilização |
WO2010101247A1 (ja) | 2009-03-05 | 2010-09-10 | 塩野義製薬株式会社 | Npy y5受容体拮抗作用を有するシクロヘキサン誘導体 |
US8816085B2 (en) * | 2009-08-26 | 2014-08-26 | Takeda Gmbh | Methylpyrrolopyridinecarboxamides |
AR077898A1 (es) | 2009-08-26 | 2011-09-28 | Nycomed Gmbh | Metilpirrolopirimidincarboxamidas |
CN103201244B (zh) * | 2010-08-26 | 2015-06-17 | 阿尔比马尔公司 | 用于制备1-溴代-2-(环丙基甲氧基)-5-氟代-4-甲氧基苯的方法 |
BR112013031791A2 (pt) | 2011-06-17 | 2017-01-31 | Takeda Gmbh | derivados de ftalazinona-pirrolopirimidinacarboxamida |
US10527935B2 (en) | 2016-12-31 | 2020-01-07 | Rohm And Haas Electronic Materials Llc | Radiation-sensitive compositions and patterning and metallization processes |
JP2020097527A (ja) * | 2017-03-31 | 2020-06-25 | 武田薬品工業株式会社 | 複素環化合物 |
KR102323090B1 (ko) * | 2017-07-07 | 2021-11-05 | 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 | 페닐 피리미돈 화합물의 염, 다형체 및 이의 약학 조성물 및 용도 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2754260B1 (fr) * | 1996-10-04 | 1998-10-30 | Adir | Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
US20050124623A1 (en) | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
AU2006221957A1 (en) * | 2005-03-09 | 2006-09-14 | Nycomed Gmbh | Amido-substituted 6-phenylphenanthridines |
-
2009
- 2009-02-20 AR ARP090100594A patent/AR070454A1/es unknown
- 2009-02-25 NZ NZ586486A patent/NZ586486A/en not_active IP Right Cessation
- 2009-02-25 EA EA201001348A patent/EA018331B1/ru not_active IP Right Cessation
- 2009-02-25 KR KR1020107021192A patent/KR20100136469A/ko not_active Application Discontinuation
- 2009-02-25 AU AU2009218507A patent/AU2009218507B2/en not_active Ceased
- 2009-02-25 CN CN2009801072042A patent/CN101959890B/zh not_active Expired - Fee Related
- 2009-02-25 JP JP2010548092A patent/JP5615187B2/ja not_active Expired - Fee Related
- 2009-02-25 WO PCT/EP2009/052198 patent/WO2009106531A1/en active Application Filing
- 2009-02-25 CA CA2711733A patent/CA2711733A1/en not_active Abandoned
- 2009-02-25 US US12/918,740 patent/US8445501B2/en not_active Expired - Fee Related
- 2009-02-25 SG SG2013014634A patent/SG188823A1/en unknown
- 2009-02-25 MX MX2010009276A patent/MX2010009276A/es active IP Right Grant
- 2009-02-25 BR BRPI0907863A patent/BRPI0907863A2/pt not_active IP Right Cessation
- 2009-02-25 MY MYPI20103000 patent/MY152061A/en unknown
- 2009-02-25 EP EP09714992A patent/EP2247594A1/en not_active Withdrawn
- 2009-02-25 UA UAA201011254A patent/UA101018C2/ru unknown
- 2009-02-26 TW TW098106249A patent/TW200944527A/zh unknown
-
2010
- 2010-06-15 CO CO10071529A patent/CO6341477A2/es active IP Right Grant
- 2010-08-16 IL IL207639A patent/IL207639A/en not_active IP Right Cessation
- 2010-08-25 EC EC2010010425A patent/ECSP10010425A/es unknown
-
2011
- 2011-07-19 HK HK11107510.3A patent/HK1153200A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1153200A1 (en) | 2012-03-23 |
EP2247594A1 (en) | 2010-11-10 |
CA2711733A1 (en) | 2009-09-03 |
JP2011513272A (ja) | 2011-04-28 |
US20110021479A1 (en) | 2011-01-27 |
UA101018C2 (ru) | 2013-02-25 |
CN101959890B (zh) | 2013-10-30 |
IL207639A0 (en) | 2010-12-30 |
IL207639A (en) | 2013-09-30 |
EA018331B1 (ru) | 2013-07-30 |
WO2009106531A1 (en) | 2009-09-03 |
AU2009218507A1 (en) | 2009-09-03 |
EA201001348A1 (ru) | 2011-04-29 |
SG188823A1 (en) | 2013-04-30 |
TW200944527A (en) | 2009-11-01 |
BRPI0907863A2 (pt) | 2019-09-24 |
KR20100136469A (ko) | 2010-12-28 |
CN101959890A (zh) | 2011-01-26 |
NZ586486A (en) | 2012-06-29 |
MX2010009276A (es) | 2010-09-14 |
AU2009218507B2 (en) | 2014-02-13 |
JP5615187B2 (ja) | 2014-10-29 |
MY152061A (en) | 2014-08-15 |
ECSP10010425A (es) | 2010-09-30 |
US8445501B2 (en) | 2013-05-21 |
AR070454A1 (es) | 2010-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6341477A2 (es) | Compuestos pirrolopirimidincarboxamida, procesos para su producción y composiciones farmaceúticas que comprenden dichos compuestos | |
CY1119669T1 (el) | Παραγωγα 1-φαινυλ-2-πυριδινυλ-αλκυλ-αλκοολων ως αναστολεις φωσφοδιεστερασης | |
CY1119004T1 (el) | Διϋδροπυριδονη p1 ως αναστολεις τελεστη χια | |
UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
CO6321282A2 (es) | Derivados de piperidinilindol como inhibidores de aldosterona sintasa | |
CO7131360A2 (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
SV2010003598A (es) | Derivados de tiazol usados como inhibidores de pi 3-cinasa | |
CL2011000589A1 (es) | Compuestos derivados de pirrolidin-2-carboxamida, inhibidores de la interaccion p53-mdm2; composicion farmaceutica que los comprende; y su uso en la preparacion de medicamentos utiles para el tratamiento del cancer. | |
CY1110108T1 (el) | Παραγωγα ισοκινολινης ως αναστολεις της rho-κινασης | |
EA201201663A1 (ru) | Производные 2-(ариламино)-3н-имидазо[4,5-b]пиридин-6-карбоксамида и их применение в качестве ингибиторов mpges-1 | |
MX2009008798A (es) | Derivados de iminipiridina y sus usos como microbicidas. | |
CR20140135A (es) | Nuevos derivados de aril-quinolina | |
UY30476A1 (es) | Noveles compuestos derivados n-sustituidos de la 3-oxoisoindolin-1-carboxamida, sus sales aceptables, composiciones farmaccuticas y aplicaciones. | |
UY29510A1 (es) | Derivados de urea, metodos para su fabricación, y usos de los mismos | |
ECSP088229A (es) | Derivados de pirazolona como inhibidores de 11-beta hsd1 | |
CU20090048A7 (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
UA106880C2 (uk) | Нові гербіциди | |
UY31933A (es) | Compuestos de sulfoximinamida para combatir plagas animales | |
ECSP088700A (es) | Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
CO6551705A2 (es) | Derivados de 3.4.4a.10b- tetrahidro-1h-tiopirano-[4.3-c]- isoquinolina | |
ATE521609T1 (de) | Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs | |
EA200901504A1 (ru) | Производные пиразолона, как ингибиторы pde4 | |
ECSP12011678A (es) | Metilpirrolopirimidincarboxamidas | |
CU20100073A7 (es) | Nuevos derivados no peptídicos como antagonistas b1 de la bradiquinina | |
GT201100039A (es) | Agentes antifúngicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |